CVSI Stock Overview
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
CV Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.039 |
| 52 Week High | US$0.06 |
| 52 Week Low | US$0.028 |
| Beta | 0.63 |
| 1 Month Change | 9.99% |
| 3 Month Change | 2.66% |
| 1 Year Change | -11.96% |
| 3 Year Change | -90.64% |
| 5 Year Change | -99.32% |
| Change since IPO | -92.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| CVSI | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0.4% | -2.9% | -3.7% |
| 1Y | -12.0% | -35.2% | 20.5% |
Return vs Industry: CVSI exceeded the US Personal Products industry which returned -35.3% over the past year.
Return vs Market: CVSI underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| CVSI volatility | |
|---|---|
| CVSI Average Weekly Movement | 9.8% |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CVSI has not had significant price volatility in the past 3 months.
Volatility Over Time: CVSI's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 43 | Joe Dowling | www.cvsciences.com |
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.
CV Sciences, Inc. Fundamentals Summary
| CVSI fundamental statistics | |
|---|---|
| Market cap | US$6.20m |
| Earnings (TTM) | US$3.10m |
| Revenue (TTM) | US$16.00m |
2.0x
P/E Ratio0.4x
P/S RatioIs CVSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CVSI income statement (TTM) | |
|---|---|
| Revenue | US$16.00m |
| Cost of Revenue | US$8.92m |
| Gross Profit | US$7.09m |
| Other Expenses | US$3.98m |
| Earnings | US$3.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.019 |
| Gross Margin | 44.27% |
| Net Profit Margin | 19.38% |
| Debt/Equity Ratio | 8.7% |
How did CVSI perform over the long term?
See historical performance and comparison